Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid in Capital [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Beginning balance at Dec. 31, 2019 $ 89,286 $ 91,126,784 $ (88,671,260) $ (37,117) $ 44,242 $ 2,551,935
Beginning balance, shares at Dec. 31, 2019 8,928,611     1,048    
Sale of common stock $ 19,392 1,480,608 1,500,000
Sale of common stock, shares 1,939,237        
Issuance of common stock $ 531 (531)
Issuance of common stock, shares 53,125        
Share-based compensation 18,680 18,680
Translation adjustments 39,873 39,873
Net loss (1,492,096) (1,492,096)
Ending balance at Mar. 31, 2020 $ 109,209 92,625,541 (90,163,356) $ (37,117) 84,115 2,618,392
Ending balance, shares at Mar. 31, 2020 10,920,973     1,048    
Beginning balance at Dec. 31, 2020 $ 128,198 95,985,080 (93,022,835) $ (37,117) 292,506 3,345,832
Beginning balance, shares at Dec. 31, 2020 12,819,843     1,048    
Sale of common stock $ 5,000 995,000 1,000,000
Sale of common stock, shares 500,000        
Issuance of common stock $ 1,500 165,000 166,500
Issuance of common stock, shares 150,000        
Cancellation of common stock $ (48) 48
Cancellation of common stock, shares (4,821)          
Share-based compensation 106,428 106,428
Translation adjustments (292,119) (292,119)
Adjustment from discontinued operations (2,591,724) (2,591,724)
Net loss (770,689) (770,689)
Ending balance at Mar. 31, 2021 $ 134,650 $ 94,659,832 $ (93,793,524) $ (37,117) $ 387 $ 964,228
Ending balance, shares at Mar. 31, 2021 13,465,022     1,048